HomeCompareNGKIF vs MRK

NGKIF vs MRK: Dividend Comparison 2026

NGKIF yields 2.16% · MRK yields 2.76%● Live data

vsPost on X →
After 10 years · $10,000 invested · DRIP enabled
🏆 MRK wins by $31.6K in total portfolio value
10 years
NGKIF
NGKIF
● Live price
2.16%
Share price
$24.00
Annual div
$0.52
5Y div CAGR
9.7%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$25.1K
Annual income
$678.16
Full NGKIF calculator →
MRK
Merck & Co. Inc.
● Live price
2.76%
Share price
$120.31
Annual div
$3.32
5Y div CAGR
32.7%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$56.8K
Annual income
$9,798.13
Full MRK calculator →

Portfolio growth — NGKIF vs MRK

📍 MRK pulled ahead of the other in Year 1

Annual dividend income

🛡️

Recession Test — Did They Cut Dividends?

How each stock treated shareholders during the 3 biggest crises of the last 20 years

Crisis PeriodNGKIFMRK
2008–2009
GFC
— No data— No data
2020 Q1–Q2
COVID
— No data— No data
2022 Q4
Rate Hike
— No data— No data
Based on dividend payment history. "Increased" = dividend grew during crisis. "Maintained" = held within 3%. "Cut" = reduced by more than 3%.
📅

Dividend Calendar Overlap

Combined, NGKIF + MRK cover 0 of 12 monthsgood coverage

Jan
Feb
Mar
Apr
May
Jun
Jul
Aug
Sep
Oct
Nov
Dec
NGKIF pays
MRK pays
Both pay
Neither
💰

Tax Bracket Optimizer

Which stock is actually better after tax? Adjust your rate to find out.

NGKIF
Annual income on $10K today (after 15% tax)
$183.65/yr
After 10yr DRIP, annual income (after tax)
$576.44/yr
MRK
Annual income on $10K today (after 15% tax)
$234.56/yr
After 10yr DRIP, annual income (after tax)
$8,328.41/yr
At 15% tax rate, MRK beats the other by $7,751.97/year in after-tax income after 10 years on $10,000
⚖️

Lazy Portfolio Split Optimizer

What's the optimal mix of NGKIF + MRK for your $10,000?

NGKIF: 50%MRK: 50%
100% MRK50/50100% NGKIF
Portfolio after 10yr
$41.0K
Annual income
$5,238.15/yr
Blended yield
12.79%
📊

Analyst Conviction Gap

Where Wall Street is most bullish on MRK right now

NGKIF
Analyst Ratings
1
Buy
1
Sell
Consensus: Buy
Altman Z
3.5
Piotroski
6/9
MRK
Analyst Ratings
25
Buy
11
Hold
1
Sell
Consensus: Buy
Price Target
$128.54
+6.8% upside vs current
Range: $100.00 — $150.00
Altman Z
4.0
Piotroski
6/9
Analyst ratings via FMP. Altman Z-Score: >3.0 safe, 1.81–3.0 grey zone, <1.81 distress. Piotroski: 7–9 strong, 0–3 weak.
🏛️

Copy Congress — What Are Politicians Buying?

Senate & House STOCK Act disclosures (last 90 days)

NGKIF buys
0
MRK buys
0
No recent congressional trades found for NGKIF or MRK in the last 90 days.
STOCK Act mandates disclosure within 45 days of transaction. Data via FMP.Full tracker →
MetricNGKIFMRK
Forward yield2.16%2.76%
Annual dividend / share$0.52$3.32
Payout ratio50%50%
1-year div growth0%0%
5-year div CAGR9.7%32.7%
Portfolio after 10y$25.1K$56.8K
Annual income after 10y$678.16$9,798.13
Total dividends collected$4.2K$28.9K
Payment frequencyquarterlyquarterly
SectorStockHealthcare
Analyst consensusBuyBuy

Year-by-year: NGKIF vs MRK ($10,000, DRIP)

YearNGKIF PortfolioNGKIF Income/yrMRK PortfolioMRK Income/yrGap
1← crossover$10,937$237.02$11,206$366.19$269.00MRK
2$11,968$265.77$12,650$502.35$682.00MRK
3$13,104$298.17$14,407$694.19$1.3KMRK
4$14,356$334.70$16,585$967.82$2.2KMRK
5$15,737$375.93$19,342$1,363.89$3.6KMRK
6$17,261$422.49$22,913$1,947.19$5.7KMRK
7$18,945$475.10$27,662$2,823.89$8.7KMRK
8$20,805$534.60$34,159$4,173.35$13.4KMRK
9$22,864$601.92$43,337$6,308.80$20.5KMRK
10$25,142$678.16$56,776$9,798.13$31.6KMRK

NGKIF vs MRK: Complete Analysis 2026

NGKIFStock

NGK Insulators, Ltd., together with its subsidiaries, manufactures and sells electric power related equipment in Japan, North America, Europe, and Asia. The company operates through Environment Business, Digital Society Business, and Energy & Industry Business segments. It offers energy storage systems, including NAS batteries; suspension, long rod, station post, hollow, and pin post insulators; HONEYCERAM, a component for exhaust gas purification; diesel particulate filters that eliminates particulates in the exhaust gas emitted from diesel automobiles; and NOx sensors, which measures nitrogen oxide concentration in motor vehicle exhaust gas. The company also provides metal-related products, such as beryllium copper products, copper-nickel-tin alloy products, molds, and related parts; and various electronic components, such as piezoelectric micro actuators, high frequency components, and mold-cast ceramics, as well as EnerCera, a chip-type ceramic rechargeable battery. In addition, it offers ceramics for semiconductor manufacturing equipment, including ceramic heaters, electrostatic chucks, and components; and industrial process products, such as heating systems, kiln furniture and refractories, ceramic membranes and separators, glass-lining products, high temperature dust collectors, ceramic and vacuum pumps, radioactive waste treatment equipment, and gas analyzers, as well as C1 home-use water Purifiers. The company was incorporated in 1919 and is headquartered in Nagoya, Japan.

Full NGKIF Calculator →

MRKHealthcare

Merck & Co., Inc. operates as a healthcare company worldwide. It operates through two segments, Pharmaceutical and Animal Health. The Pharmaceutical segment offers human health pharmaceutical products in the areas of oncology, hospital acute care, immunology, neuroscience, virology, cardiovascular, and diabetes, as well as vaccine products, such as preventive pediatric, adolescent, and adult vaccines. The Animal Health segment discovers, develops, manufactures, and markets veterinary pharmaceuticals, vaccines, and health management solutions and services, as well as digitally connected identification, traceability, and monitoring products. It serves drug wholesalers and retailers, hospitals, and government agencies; managed health care providers, such as health maintenance organizations, pharmacy benefit managers, and other institutions; and physicians and physician distributors, veterinarians, and animal producers. The company has collaborations with AstraZeneca PLC; Bayer AG; Eisai Co., Ltd.; Ridgeback Biotherapeutics; and Gilead Sciences, Inc. to jointly develop and commercialize long-acting treatments in HIV. Merck & Co., Inc. was founded in 1891 and is headquartered in Kenilworth, New Jersey.

Full MRK Calculator →
📬

Get this NGKIF vs MRK comparison by email

Save your analysis + weekly dividend insights. Free forever.

More comparisons

NGKIF vs SCHDNGKIF vs JEPINGKIF vs ONGKIF vs KONGKIF vs MAINNGKIF vs JNJNGKIF vs ABBVNGKIF vs PFE

⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.